Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04925544
Title Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV) Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV) Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University
Indications

nasopharynx carcinoma

lymphoma

Therapies

VK-2019

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.